Silva, B. V.Calhaz-Jorge, CarlosRigueira, JoanaRodrigues, TiagoSilverio Antonio, P.Morais, PedroPereira, S.Alves Da Silva, P.Brito, J.Plácido, RuiAlmeida, Ana G.Pinto, Fausto J.2022-01-142022-01-142021European Heart Journal - Cardiovascular Imaging, Vol. 22, Issue Supp. 3, June 2021, jeab111.0092047-2404http://hdl.handle.net/10451/50822Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2021. For permissions please email: Journals.permissions@oup.com. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)Pulmonary embolism (PE) is a recognized complication of SARS-COV2 infection due to hypercoagulability. Before the COVID era, the need for computed tomography pulmonary angiography (CTPA) to rule out PE was determined by clinical probability, based on Wells and Geneva scores, in association with D-dimer measurements. However, patients with SARS-COV2 infection have a pro-thrombotic and pro-inflammatory state which may compromise the usefulness of these algorithms to select patients for CTPA.engjournal article10.1093/ehjci/jeab111.0092047-2412